Real-time continuous glucose monitoring (CGM) devices have been shown to detect greater glucose variability, rate of change (ROC) in glucose concentration, and incidence of hypoglycemia compared with self-monitoring of blood glucose (SMBG) using a traditional glucose meter and capillary blood sampling.1,2 Since CGM systems can provide insight into glucose patterns and overall diabetes management, these devices have recently been included in the clinical guidelines and standards of care for patients living with diabetes, particularly if they are dosing insulin.3,4. Here, INS is linked to diabetes mellitus.